Carregant...
A Cost Analysis of Gyrase A Testing and Targeted Ciprofloxacin Therapy vs. Recommended Two-Drug Therapy for Neisseria gonorrhoeae Infection
BACKGROUND: Novel approaches to combating drug-resistant Neisseria gonorrhoeae infections are urgently needed. Targeted therapy with ciprofloxacin has been made possible by a rapid assay for genotyping the gyrase A (gyrA) gene; a non-mutated gene reliably predicts susceptibility to ciprofloxacin. ME...
Guardat en:
| Publicat a: | Sex Transm Dis |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6879096/ https://ncbi.nlm.nih.gov/pubmed/29329176 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/OLQ.0000000000000698 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|